Palisade Bio (PALI) Return on Capital Employed Growth (3y) (2014 - 2026)
Palisade Bio (PALI) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4,893.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2,416.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,782.00 |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | 8,049.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,049.00 |
| Dec 31, 2025 | 9,356.00 |
| Sep 30, 2025 | -15,626.00 |
| Jun 30, 2025 | -7,273.00 |
| Mar 31, 2025 | 31,143.00 |
| Dec 31, 2024 | 13,559.00 |
| Sep 30, 2024 | 14,991.00 |
| Jun 30, 2024 | 34,409.00 |
| Mar 31, 2024 | 4,825.00 |
| Dec 31, 2023 | 77,772.00 |
| Sep 30, 2023 | -4,017.00 |
| Jun 30, 2023 | -4,004.00 |
| Mar 31, 2023 | 372.00 |
| Dec 31, 2022 | 1,110.00 |
| Sep 30, 2022 | -802.00 |
| Jun 30, 2022 | -3,438.00 |
| Mar 31, 2022 | -35,430.00 |
| Dec 31, 2021 | -22,764.00 |
| Sep 30, 2021 | -20,400.00 |
| Jun 30, 2021 | -39,748.00 |